(UGI) UGI - Overview
Stock: Propane, Natural Gas, Electricity, LPG, Midstream
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.25% |
| Yield on Cost 5y | 5.07% |
| Yield CAGR 5y | 2.39% |
| Payout Consistency | 74.9% |
| Payout Ratio | 61.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 18.7% |
| Relative Tail Risk | -8.54% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.81 |
| Alpha | 14.16 |
| Character TTM | |
|---|---|
| Beta | 0.440 |
| Beta Downside | 0.439 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.25% |
| CAGR/Max DD | 0.07 |
Description: UGI UGI January 06, 2026
UGI Corporation (NYSE: UGI) is a diversified energy-distribution company operating four business segments-Utilities, Midstream & Marketing, UGI International, and AmeriGas Propane-that together serve roughly 801 million end-users across residential, commercial, industrial, agricultural, motor-fuel and wholesale markets.
Through its Utilities arm, UGI delivers natural gas to about 694 k customers via 12,700 mi of pipelines in eastern and central Pennsylvania and supplies electricity to roughly 62.9 k customers through 2,700 mi of lines and 14 substations. The Midstream & Marketing segment handles LPG (propane) logistics, storage, and vaporization, while AmeriGas is the largest U.S. propane retailer, serving both residential and commercial accounts.
Key operating metrics (FY 2023) include total revenue of ≈ $2.5 billion, adjusted EBITDA of $300 million (≈ 12 % margin), and a pipeline utilization rate of roughly 78 %. The business is sensitive to seasonal propane demand, natural-gas price volatility, and regulatory changes affecting utility rates and emissions standards.
Investors should watch macro drivers such as U.S. residential heating demand, the pace of natural-gas price rebounds after the 2023-24 winter, and capital-expenditure cycles for pipeline upgrades, which historically influence UGI’s cash-flow stability.
For a deeper, data-driven analysis of UGI’s valuation dynamics, consider exploring the detailed metrics and scenario models on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 600.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.74 > 1.0 |
| NWC/Revenue: -7.90% < 20% (prev 0.11%; Δ -8.01% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.13b > Net Income 600.0m |
| Net Debt (6.52b) to EBITDA (1.46b): 4.47 < 3 |
| Current Ratio: 0.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (221.4m) vs 12m ago 2.65% < -2% |
| Gross Margin: 57.93% > 18% (prev 0.45%; Δ 5748 % > 0.5%) |
| Asset Turnover: 47.01% > 50% (prev 46.20%; Δ 0.81% > 0%) |
| Interest Coverage Ratio: 2.14 > 6 (EBITDA TTM 1.46b / Interest Expense TTM 420.0m) |
Altman Z'' 1.37
| A: -0.04 (Total Current Assets 2.10b - Total Current Liabilities 2.68b) / Total Assets 15.81b |
| B: 0.22 (Retained Earnings 3.55b / Total Assets 15.81b) |
| C: 0.06 (EBIT TTM 897.0m / Avg Total Assets 15.61b) |
| D: 0.47 (Book Value of Equity 5.11b / Total Liabilities 10.80b) |
| Altman-Z'' Score: 1.37 = BB |
Beneish M -3.37
| DSRI: 0.87 (Receivables 1.05b/1.17b, Revenue 7.34b/7.12b) |
| GMI: 0.77 (GM 57.93% / 44.75%) |
| AQI: 0.97 (AQ_t 0.29 / AQ_t-1 0.30) |
| SGI: 1.03 (Revenue 7.34b / 7.12b) |
| TATA: -0.03 (NI 600.0m - CFO 1.13b) / TA 15.81b) |
| Beneish M-Score: -3.37 (Cap -4..+1) = AA |
What is the price of UGI shares?
Over the past week, the price has changed by -7.53%, over one month by -0.62%, over three months by +11.06% and over the past year by +20.91%.
Is UGI a buy, sell or hold?
- StrongBuy: 3
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the UGI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.5 | 20% |
| Analysts Target Price | 44.5 | 20% |
| ValueRay Target Price | 42 | 13.3% |
UGI Fundamental Data Overview February 07, 2026
P/E Forward = 7.728
P/S = 1.1152
P/B = 1.8162
P/EG = 2.65
Revenue TTM = 7.34b USD
EBIT TTM = 897.0m USD
EBITDA TTM = 1.46b USD
Long Term Debt = 6.53b USD (from longTermDebt, last fiscal year)
Short Term Debt = 807.0m USD (from shortTermDebt, last quarter)
Debt = 6.77b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.52b USD (from netDebt column, last quarter)
Enterprise Value = 14.65b USD (8.13b + Debt 6.77b - CCE 251.0m)
Interest Coverage Ratio = 2.14 (Ebit TTM 897.0m / Interest Expense TTM 420.0m)
EV/FCF = 29.12x (Enterprise Value 14.65b / FCF TTM 503.0m)
FCF Yield = 3.43% (FCF TTM 503.0m / Enterprise Value 14.65b)
FCF Margin = 6.85% (FCF TTM 503.0m / Revenue TTM 7.34b)
Net Margin = 8.17% (Net Income TTM 600.0m / Revenue TTM 7.34b)
Gross Margin = 57.93% ((Revenue TTM 7.34b - Cost of Revenue TTM 3.09b) / Revenue TTM)
Gross Margin QoQ = none% (prev 39.26%)
Tobins Q-Ratio = 0.93 (Enterprise Value 14.65b / Total Assets 15.81b)
Interest Expense / Debt = 1.64% (Interest Expense 111.0m / Debt 6.77b)
Taxrate = 15.38% (54.0m / 351.0m)
NOPAT = 759.0m (EBIT 897.0m * (1 - 15.38%))
Current Ratio = 0.78 (Total Current Assets 2.10b / Total Current Liabilities 2.68b)
Debt / Equity = 1.35 (Debt 6.77b / totalStockholderEquity, last quarter 5.00b)
Debt / EBITDA = 4.47 (Net Debt 6.52b / EBITDA 1.46b)
Debt / FCF = 12.97 (Net Debt 6.52b / FCF TTM 503.0m)
Total Stockholder Equity = 4.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.84% (Net Income 600.0m / Total Assets 15.81b)
RoE = 12.21% (Net Income TTM 600.0m / Total Stockholder Equity 4.92b)
RoCE = 7.84% (EBIT 897.0m / Capital Employed (Equity 4.92b + L.T.Debt 6.53b))
RoIC = 6.36% (NOPAT 759.0m / Invested Capital 11.93b)
WACC = 4.74% (E(8.13b)/V(14.90b) * Re(7.54%) + D(6.77b)/V(14.90b) * Rd(1.64%) * (1-Tc(0.15)))
Discount Rate = 7.54% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.35%
[DCF Debug] Terminal Value 84.80% ; FCFF base≈452.2m ; Y1≈392.9m ; Y5≈314.0m
Fair Price DCF = 14.02 (EV 9.53b - Net Debt 6.52b = Equity 3.01b / Shares 214.8m; r=5.90% [WACC]; 5y FCF grow -16.02% → 2.90% )
EPS Correlation: -2.84 | EPS CAGR: -10.50% | SUE: -0.11 | # QB: 0
Revenue Correlation: -48.17 | Revenue CAGR: -12.74% | SUE: -1.45 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.16 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-09-30): EPS=3.10 | Chg30d=-0.035 | Revisions Net=-3 | Growth EPS=-6.8% | Growth Revenue=+7.8%
EPS next Year (2027-09-30): EPS=3.40 | Chg30d=+0.025 | Revisions Net=-2 | Growth EPS=+9.7% | Growth Revenue=+2.3%